Overview
CCRN market data
Price History
CCRN price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$2.93 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.39 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- — Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $7.43 – $14.99 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · source Twelve Data /statistics · market cap $427.3 · P/B 0.82 · P/S 0.43.
Company news
$HAREHOLDER ALERT: The M&A Class Action Firm Encourages $hareholders to Act Before the Vote—Cross Country Healthcare, Inc. (NASDAQ: CCRN)Globenewswire Inc · Jul 15, 2026, 3:15 PM
8-K filing — CROSS COUNTRY HEALTHCARE INC (CCRN)SEC EDGAR · Jul 6, 2026, 10:17 AM
The M&A Class Action Firm Encourages $hareholders to Contact Monteverde Concerning The Merger—PFLC, NUVL, CCRN, and BGMSGlobenewswire Inc · Jun 18, 2026, 11:15 PM
CCRN Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Cross Country Healthcare to Knox LaneGlobenewswire Inc · May 13, 2026, 2:15 PM
Truist Securities Maintains Hold on Cross Country Healthcare, Raises Price Target to $13.25Benzinga · May 11, 2026, 2:51 PM